Cassava Sciences Completes Patient Dosing in a Randomized Co

The Cognition Maintenance Study is a 6-month, Randomized Controlled Trial of Simufilam in Over 125 Patients with Alzheimer’s Disease.Primary Outcome Measures Are Safety and Change in Cognition... | May 11, 2023

Related Keywords

Texas , United States , Eric Schoen , Remi Barbier , Cassava Sciences Inc , Nasdaq , Cassava Sciences , Cognition Maintenance Study , Randomized Controlled Trial , Outcome Measures Are Safety , Clinical Results , Cassava Science , More Information Contact , Chief Financial , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Nc Stock Exchange , News , Information , Press Release , The , Cognition , Maintenance , Study , Us , Randomized , Ontrolled , Trial , F , Simufilam , N , Dover , 25 , Patients , Ith , Outcome , Measures , Fire , Safety , End , Change , N Sava Us14817c1071 ,